ADMA
🟢 ADMA Biologics is trading 7.5% up in pre-market on positive Moderna and Merck Phase 3 results
ADMA Biologics is trading 7.5% up at $10.80, primarily on biotech-sector strength following positive Phase 3 personalized cancer-vaccine results from Moderna...